News June 22, 2022
BURLINGTON, Mass. and JERUSALEM, June 22, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News June 21, 2022
Highmark BCBS Covers 6.8 Million Members in Four States BURLINGTON, Mass. and JERUSALEM, June 21, 2022...
News May 11, 2022
Revenue Growth of 30% Year-over-Year in Q1 2022 Conference call to be held today, May 11, 2022, at 8:30...
News May 9, 2022
Veteran Medical Device Industry Sales and Marketing Executive Has Over 20 Years of Experience BURLINGTON,...
News May 4, 2022
Additional presentations will highlight the utility of Deep TMS™ in Smoking Addiction and OCD BURLINGTON,...
News May 2, 2022
BrainsWay will donate $5 per share, $2 per comment, and $1 per like to support the work of Mental Health...
News April 27, 2022
BURLINGTON, Mass. and JERUSALEM, April 27, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News March 28, 2022
Dr. Seidel has more than 20 years of experience in the medical device industry BURLINGTON, Mass. and...
News March 15, 2022
BURLINGTON, Mass. and JERUSALEM, March 15, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News March 9, 2022
Revenue Growth of 34% in 2021, with Record Quarterly and Annual Revenues Continued Progress in Expanding...
News March 1, 2022
BURLINGTON, Mass. and JERUSALEM, March 01, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News February 28, 2022
BURLINGTON, Mass. and JERUSALEM, Feb. 28, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News February 23, 2022
Results Distinguish Deep TMS as More Effective in Subjects with Higher Anxiety Symptoms, Long Considered...
News February 1, 2022
BURLINGTON, Mass. and JERUSALEM, February 1, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News January 31, 2022
Palmetto GBA Covers Medicare Patients in Seven States BURLINGTON, Mass. and JERUSALEM, January 31, 2022...
News January 26, 2022
World-Renowned Specialist in Addiction and Anxiety Treatment Joins Premier Group of Researchers and Clinicians...
News January 12, 2022
Positive Data Support the Durability and Cost-Effectiveness of Deep TMS as a Treatment for Obsessive-Compulsive...
News December 9, 2021
Randomized, Placebo-Controlled, Double-Blind Pilot Study Evaluated Deep TMS Treatment in Reducing Alcohol...